Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL vs. Bupivacaine HCl for Postsurgical Analgesia in Total Ankle Arthroplasty
NCT07212114Phase 3Recruiting
- Sponsor
- Emory University
- Start
- Nov 2025
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in Persistent postsurgical pain (PPSP), sponsored by Emory University. Started Nov 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT07212114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07212114.